<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Reports of similar age-specific incidence rates and a female-to-male gender disparity by racial/ethnic groups suggests that further consideration of race-specific patterns may confer insight into the possible causes of <z:e sem="disease" ids="C0007115" disease_type="Neoplastic Process" abbrv="">thyroid cancer</z:e> or explanations for the increase in incidence </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We used the National <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Institute's (NCIs) surveillance, epidemiology, and end results (SEER) program and Joinpoint Regression for cases diagnosed during 1992-2009 to investigate trends and rates of acceleration for <z:e sem="disease" ids="C0238463" disease_type="Neoplastic Process" abbrv="FNMTC|NMTC">papillary thyroid cancer</z:e> by gender and race/ethnicity </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: We determined the annual percent change (APC) and found a yearly increase of 7.0 % for <z:e sem="disease" ids="C0238463" disease_type="Neoplastic Process" abbrv="FNMTC|NMTC">papillary thyroid cancer</z:e> for the most recent APC trend, with an APC of 6.3 and 7.1 % for white males and females, respectively; an APC of 4.3 and 8.4 % for black males and females, respectively; an APC of 4.2 and 6.7 % for Hispanic males and females, respectively; and an APC of 3.4 and 6.4 % in Asian/PI males and females, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>The APC projections show the rates of <z:e sem="disease" ids="C0238463" disease_type="Neoplastic Process" abbrv="FNMTC|NMTC">papillary thyroid cancer</z:e> rising in males, but the patterns are more dramatic in females, with rates of <z:e sem="disease" ids="C0238463" disease_type="Neoplastic Process" abbrv="FNMTC|NMTC">papillary thyroid cancer</z:e> in females surpassing rates of common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> and becoming the third most common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in women of <z:hpo ids='HP_0000001'>all</z:hpo> ages by 2019 </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSIONS: Although the lowest rates of <z:e sem="disease" ids="C0007115" disease_type="Neoplastic Process" abbrv="">thyroid cancer</z:e> are observed in blacks, the greatest rate of acceleration is occurring in black females </plain></SENT>
<SENT sid="5" pm="."><plain>Our data also show that the rate of <z:e sem="disease" ids="C0238463" disease_type="Neoplastic Process" abbrv="FNMTC|NMTC">papillary thyroid cancer</z:e> will continue to surpass rates of <z:e sem="disease" ids="C1140680" disease_type="Neoplastic Process" abbrv="">ovarian cancer</z:e>, and in white women: it is projected to be more incident than <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> as well; and in Hispanic and Asian/Pacific Islander women, rates of <z:e sem="disease" ids="C0238463" disease_type="Neoplastic Process" abbrv="FNMTC|NMTC">papillary thyroid cancer</z:e> are projected to be higher than lung, colorectal, and <z:e sem="disease" ids="C1140680" disease_type="Neoplastic Process" abbrv="">ovarian cancers</z:e> in the near future </plain></SENT>
</text></document>